Treatment of streptozocin (STZ)-induced diabetic rats with sodium selenate (10–15 μmol · kg−1 · day−1) for 7 wk resulted in a decrease in plasma glucose, food intake, and water intake to control or near control levels. Plasma insulin was reduced in control rats given sodium selenate to the level found in the diabetic and treated diabetic group. Treatment did not affect control rats with regard to the other measurements cited. Sodium selenate enhanced weight gain in responding diabetic rats to that seen in controls; sodium selenate's actions thus resembled those of insulin. Thus selenate, like vanadium, appears to have insulinlike effects when administered in vivo.
Skip Nav Destination
Original Articles| December 01 1991
Insulinlike Effects of Sodium Selenate in Streptozocin-Induced Diabetic Rats
John H McNeill;
Heather L M Delgatty;
Address correspondence and reprint requests to John H. McNeill, PhD, Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.
- Views Icon Views
- PDF LinkPDF
- Share Icon Share
John H McNeill, Heather L M Delgatty, Mary L Battell; Insulinlike Effects of Sodium Selenate in Streptozocin-Induced Diabetic Rats. Diabetes 1 December 1991; 40 (12): 1675–1678. https://doi.org/10.2337/diab.40.12.1675
Download citation file: